JR
Highly rated in
3
conditions
Highly rated in
3
conditions

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

About Dr. Jacques Rahier

Jacques Rahier is in Brussels, Belgium. Dr. Rahier is highly rated in 3 conditions, according to our data. His top areas of expertise are Newborn Low Blood Sugar, Congenital Hyperinsulinism, Low Blood Sugar, and Sotos Syndrome.

His clinical research consists of co-authoring 36 peer reviewed articles in the past 15 years.

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Locations
  Brussels, BRU, BE
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Université Libre De Bruxelles
 
Brussels, BRU, BE 
 0.1 km
Massimo Pandolfo is in Brussels, Belgium. They have been an author on 141 peer reviewed articles and participated in 7 clinical trials in the past 15 years.
Highly rated in
0
conditions
Société De Recherche Pour L'Infertilité
 
Brussels, BRU, BE 
 0.1 km
Jacques Donnez is in Brussels, Belgium. They have been an author on 273 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
Vrije Universiteit Brussel
 
Brussels, BRU, BE 1090
 0.1 km
Yvan Vandenplas is in Brussels, Belgium. They have been an author on 316 peer reviewed articles and participated in 52 clinical trials in the past 15 years.